BMY shareholders elect all 11 directors, pass say-on-pay, stock plan, auditor; independent chair proposal fails

The management proposal on the advisory vote to approve the compensation of our named executive officers was approved based upon the following votes: For Against Abstain Broker Non-Vote 1,459,162,310 72,490,026 6,933,061 234,927,659

The appointment of Deloitte & Touche LLP as independent registered public accounting firm for the Company for 2026 was ratified based upon the following votes: For Against Abstain 1,706,279,839 63,727,901 3,505,316

The shareholder proposal on the adoption of a board policy that the chairperson of the board be an independent director was not approved based upon the following votes: For Against Abstain Broker Non-Vote 422,069,323 1,109,378,680 7,137,394 234,927,659

The management proposal on the vote to approve the Company’s 2026 stock award and incentive plan was approved based upon the following votes: For Against Abstain Broker Non-Vote 1,470,672,957 63,896,918 4,015,522 234,927,659

The shareholders elected each of the Company’s 11 nominees to serve as directors of the Company until the 2027 Annual Meeting based upon the following votes: For Against Abstain Broker Non-Vote Peter J. Arduini 1,489,115,718 46,952,408 2,517,271 234,927,659 Deepak L. Bhatt, M.D., M.P.H., M.B.A. 1,519,336,832 16,821,065 2,427,500 234,927,659 Christopher S. Boerner, Ph.D. 1,462,672,450 73,500,542 2,412,405 234,927,659 Julia A. Haller, M.D. 1,513,280,188 23,027,628 2,277,581 234,927,659 Manuel Hidalgo Medina, M.D., Ph.D. 1,513,107,431 23,055,022 2,422,944 234,927,659 Michael R. McMullen 1,520,590,126 15,506,431 2,488,840 234,927,659 Paula A. Price 1,506,560,939 29,652,099 2,372,359 234,927,659 Derica W. Rice 1,493,345,909 42,806,350 2,433,138 234,927,659 Theodore R. Samuels 1,487,884,432 48,111,146 2,589,819 234,927,659 Karen H. Vousden, Ph.D. 1,519,199,326 17,078,052 2,308,019 234,927,659 Phyllis R. Yale 1,527,736,604 8,485,885 2,362,908 234,927,659